CN103048319B - Method for detecting residual disinfecting Cetyltrimethylammonium Chloride used in production process of sodium hyaluronate - Google Patents

Method for detecting residual disinfecting Cetyltrimethylammonium Chloride used in production process of sodium hyaluronate Download PDF

Info

Publication number
CN103048319B
CN103048319B CN201210563535.0A CN201210563535A CN103048319B CN 103048319 B CN103048319 B CN 103048319B CN 201210563535 A CN201210563535 A CN 201210563535A CN 103048319 B CN103048319 B CN 103048319B
Authority
CN
China
Prior art keywords
hexadecyltrimethylammonium chloride
solution
hydrochloric acid
ctac
sodium hyaluronate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210563535.0A
Other languages
Chinese (zh)
Other versions
CN103048319A (en
Inventor
叶湘武
付爱玲
邱永锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Jingfeng Pharmaceutical Co., Ltd.
Original Assignee
SHANGHAI JINGFENG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI JINGFENG PHARMACEUTICAL CO Ltd filed Critical SHANGHAI JINGFENG PHARMACEUTICAL CO Ltd
Priority to CN201210563535.0A priority Critical patent/CN103048319B/en
Publication of CN103048319A publication Critical patent/CN103048319A/en
Application granted granted Critical
Publication of CN103048319B publication Critical patent/CN103048319B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to a method for detecting residual disinfecting Cetyltrimethylammonium Chloride (CTAC) used in the production process of sodium hyaluronate. The method comprises the following steps: preparing a CTAC standard solution to structure a linear regression equation; preparing a sample solution, using an improved bismuth potassium iodide test solution for developing and measuring the absorbency value; and calculating the content of the CTAC with the linear regression equation. The structuring method of the linear regression equation is as follows: after using the improved bismuth potassium iodide test solution for developing of the prepared 2 Mug/ml, 4 Mug/ml, 8 Mug/ml, 10 Mug/ml and 20 Mug/ml standard solutions, measuring the absorbency under 290nm. By adopting the method to detect the content of the CTAC, the shortcoming that the content and the residue of the CTAC serving as a disinfectant or a reaction agent can not be monitored at present can be overcome, the detection time is greatly shortened, and the detection cost is lowered. The method provided by the invention is particularly suitable for detecting CTAC in labs.

Description

The detection method of the residual hexadecyltrimethylammonium chloride of sterilization in a kind of sodium hyaluronate production run
Technical field:
The present invention relates to a kind of detection method of hexadecyltrimethylammonium chloride, is espespecially the detection method of the hexadecyltrimethylammonium chloride that in production run, cleaning-sterilizing remains.
Background technology:
The Chinese another name of hexadecyltrimethylammonium chloride: cetane trimethyl ammonium chloride; CTAC; 1631, chlorination trimethylcetylammonium.
English name: Hexadecyl trimethylammonium chloride, structural formula is as follows:
English another name: CTAC; Cetyltrimethylammonium chloride
No. CAS: 112-02-7
Molecular formula: C19H42ClN
Linear formula: CH3 (CH2) 15N (Cl) (CH3) 3
Molecular weight: 320.00
Purity: >=99%
No. MDL: MFCD00011773
No. Beilstein: 3657974
No. EC: 203-928-6
Hexadecyltrimethylammonium chloride is white crystalline powder, is soluble in isopropyl alcohol, water soluble, produces a large amount of foam during concussion, can have good compatibility with kation, nonionic, amphoteric surfactant; Chemical stability is good, heat-resisting, fast light, withstand voltage, strong alkali-acid resistance; There is excellent infiltration, softening, emulsification, antistatic, the performance such as biodegradability and sterilization.Be widely used in medical industry auxiliary agent, protein flocculation and water treatment flocculation, sanitizer, cleaning and disinfecting sterilization etc.
Hexadecyltrimethylammonium chloride MSDS data is shown as toxicity 4 grades, moderate toxicity, and LD50 is 400mg/kg.Therefore consider in view of the safety in utilization of product, be necessary to carry out the detection of residual quantity limit to CTAC residual in product.In document disclosed at present, no matter be American Pharmacopeia or Japanese Pharmacopoeia, there is no the detection method for this content of material or residual volume at present.
Summary of the invention:
The object of this invention is to provide the detection method of the residual hexadecyltrimethylammonium chloride of sterilization in a kind of sodium hyaluronate production run, caused safety issue is remained to solve hexadecyltrimethylammonium chloride, the method detects accurately, and inspection cost, checkability are high, inspection work is carried out conveniently.
For realizing object of the present invention, the technical solution adopted in the present invention is:
A detection method for the residual hexadecyltrimethylammonium chloride of sterilization in sodium hyaluronate production run, is characterized in that, comprise the following steps:
(1) preparation of typical curve: take hexadecyltrimethylammonium chloride reference substance, adds hydrochloric acid solution and the constant volume that is dissolved in water, is mixed with hexadecyltrimethylammonium chloride storing solution; Hexadecyltrimethylammonium chloride storing solution is diluted, is mixed with the hexadecyltrimethylammonium chloride titer of 2 μ g/ml, 4 μ g/ml, 8 μ g/ml, 10 μ g/ml, 20 μ g/ml; Pipette each hexadecyltrimethylammonium chloride titer of certain volume, be placed in test tube, the isopyknic described hydrochloric acid solution of titer is pipetted in two blank tubes, improvement bismuth potassium iodide test solution is added in above-mentioned each pipe, immediately in the mixing of vortex oscillator, room temperature places 5-15min, take blank tube as contrast, survey the absorbance under 290nm, draw linear regression equation;
(2) sample solution preparation: take/pipette hexadecyltrimethylammonium chloride sample, be dissolved in water after adding described hydrochloric acid solution constant volume, adds improvement bismuth potassium iodide test solution, mix at vortex oscillator immediately, room temperature places 5-15min, take blank tube as contrast, surveys the absorbance under 290nm; Described hexadecyltrimethylammonium chloride sample is after using hexadecyltrimethylammonium chloride sterilization, the Liquid Residue that may contain hexadecyltrimethylammonium chloride after cleaning up by purified water;
(3) by linear regression equation, the content of hexadecyltrimethylammonium chloride is calculated.
In a preferred embodiment of the invention, the concentration of described hydrochloric acid solution is 0.6mol/L; Wherein in step (1) and step (2), the amount adding hydrochloric acid solution is 2ml.
In a preferred embodiment of the invention, in step (1) and step (2), the amount adding improvement bismuth potassium iodide test solution is 0.5ml.
The preparation method of described improvement bismuth potassium iodide test solution gets basic bismuth nitrate 0.85g, adds after glacial acetic acid 10ml and water 40ml dissolves, adds liquor kalii iodide (4 → 10) 20ml, shake up to obtain test solution, then pipette above-mentioned test solution 1ml, add 0.6mol/L hydrochloric acid solution 2ml, add water to 10ml, to obtain final product.
In a preferred embodiment of invention, in step (2), the amount taking/pipette hexadecyltrimethylammonium chloride sample is 10mg.
The Cleaning Principle of the detection method of hexadecyltrimethylammonium chloride of the present invention reacts according to the amino contained in hexadecyltrimethylammonium chloride molecule and improvement bismuth potassium iodide test solution, produce violet compound, this compound can produce absorption maximum at 290nm place.
Method of the present invention is utilized to detect hexadecyltrimethylammonium chloride content, make up current hexadecyltrimethylammonium chloride as the shortcoming cannot monitoring its content and residual volume when sanitizer or reaction reagent, substantially reduce detection time, reduce testing cost, be particularly suitable for the detection that the right hexadecyltrimethylammonium chloride content in laboratory carries out.
Embodiment
Can be well understood to the present invention further by specific embodiments of the invention given below, but they not limitation of the invention.
Embodiment
(1) take hexadecyltrimethylammonium chloride reference substance, add 0.6mol/L hydrochloric acid solution 2ml, be dissolved in water constant volume, is mixed with the hexadecyltrimethylammonium chloride storing solution of 200 μ g/ml; Hexadecyltrimethylammonium chloride storing solution is diluted, is mixed with the titer of 1 μ g/ml, 2 μ g/ml, 4 μ g/ml, 8 μ g/ml, 10 μ g/ml; Pipette each titer of certain volume, be placed in test tube, the isopyknic 0.6mol/L hydrochloric acid solution of titer is pipetted in two blank tubes, improvement bismuth potassium iodide test solution 0.5ml is added in above-mentioned each pipe, immediately in the mixing of vortex oscillator, room temperature places 5-15min, take blank tube as contrast, survey the absorbance under 290nm, draw linear regression equation;
(2) sample solution preparation: take/pipette hexadecyltrimethylammonium chloride sample 5ml, add 0.6mol/L hydrochloric acid solution 2ml, be dissolved in water and be settled to 10ml, add improvement bismuth potassium iodide test solution 0.5ml, mix at vortex oscillator immediately, room temperature places 5-15min, take blank tube as contrast, surveys the absorbance under 290nm; Hexadecyltrimethylammonium chloride sample is after using hexadecyltrimethylammonium chloride sterilization, the Liquid Residue that may contain hexadecyltrimethylammonium chloride after cleaning up by purified water.
(3) by linear regression equation, the content of hexadecyltrimethylammonium chloride is calculated.
Improvement bismuth potassium iodide test solution gets basic bismuth nitrate 0.85g, adds after glacial acetic acid 10ml and water 40ml dissolves, add liquor kalii iodide (4 → 10) 20ml, shake up, then pipette above-mentioned test solution 1ml, add 0.6mol/L hydrochloric acid solution 2ml, add water to 10ml, to obtain final product.
Test findings:
After using hexadecyltrimethylammonium chloride sterilization according to the method for above-described embodiment to three times, the three place's Liquid Residue content detection that may contain hexadecyltrimethylammonium chloride after cleaning up by purified water the results are shown in Table 1:
Table 1
As known from Table 1, after method of the present invention uses hexadecyltrimethylammonium chloride sterilization to three times, may test by three place's Liquid Residues containing hexadecyltrimethylammonium chloride after cleaning up by purified water, compensate for the blank not having the method at present, improves detection efficiency, accelerate sample dissolution, sample is easy to mixing, avoids the metrical error because incomplete mixing brings, and reduces the use amount of reagent, reduce inspection cost, ensure that the safety of medicine.

Claims (5)

1. in sodium hyaluronate production run, sterilization remains a detection method for hexadecyltrimethylammonium chloride, it is characterized in that, comprises the following steps:
(1) preparation of typical curve: take hexadecyltrimethylammonium chloride reference substance, adds hydrochloric acid solution and the constant volume that is dissolved in water, is mixed with hexadecyltrimethylammonium chloride storing solution; Hexadecyltrimethylammonium chloride storing solution is diluted, is mixed with the hexadecyltrimethylammonium chloride titer of 1 μ g/ml, 2 μ g/ml, 4 μ g/ml, 8 μ g/ml, 10 μ g/ml; Pipette each hexadecyltrimethylammonium chloride titer of certain volume, be placed in test tube, the isopyknic described hydrochloric acid solution of titer is pipetted in two blank tubes, improvement bismuth potassium iodide test solution is added in above-mentioned each pipe, immediately in the mixing of vortex oscillator, room temperature places 5-15min, take blank tube as contrast, survey the absorbance under 290nm, draw linear regression equation;
(2) sample solution preparation: take/pipette hexadecyltrimethylammonium chloride sample, be dissolved in water after adding described hydrochloric acid solution constant volume, adds improvement bismuth potassium iodide test solution, mix at vortex oscillator immediately, room temperature places 5-15min, take blank tube as contrast, surveys the absorbance under 290nm; Described hexadecyltrimethylammonium chloride sample is after using hexadecyltrimethylammonium chloride sterilization, the Liquid Residue that may contain hexadecyltrimethylammonium chloride after cleaning up by purified water;
(3) by linear regression equation, the content of hexadecyltrimethylammonium chloride is calculated.
2. the detection method of hexadecyltrimethylammonium chloride as claimed in claim 1, it is characterized in that, the concentration of described hydrochloric acid solution is 0.6mol/L; Wherein in step (1) and step (2), the amount adding hydrochloric acid solution is 2ml.
3. the detection method of the residual hexadecyltrimethylammonium chloride of sterilization in a kind of sodium hyaluronate production run as claimed in claim 1, is characterized in that, in step (1) and step (2), adding the amount improveing bismuth potassium iodide test solution is 0.5ml.
4. in a kind of sodium hyaluronate production run as claimed in claim 1, sterilization remains the detection method of hexadecyltrimethylammonium chloride, it is characterized in that, the preparation method of described improvement bismuth potassium iodide test solution gets basic bismuth nitrate 0.85g, add after glacial acetic acid 10ml and water 40ml dissolves, add liquor kalii iodide (4 → 10) 20ml, shake up to obtain test solution, pipette above-mentioned test solution 1ml again, add 0.6mol/L hydrochloric acid solution 2ml, add water to 10ml, to obtain final product.
5. in a kind of sodium hyaluronate production run as claimed in claim 1, sterilization remains the detection method of hexadecyltrimethylammonium chloride, and it is characterized in that, in step (2), the amount taking/pipette hexadecyltrimethylammonium chloride sample is 10mg.
CN201210563535.0A 2012-12-21 2012-12-21 Method for detecting residual disinfecting Cetyltrimethylammonium Chloride used in production process of sodium hyaluronate Active CN103048319B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210563535.0A CN103048319B (en) 2012-12-21 2012-12-21 Method for detecting residual disinfecting Cetyltrimethylammonium Chloride used in production process of sodium hyaluronate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210563535.0A CN103048319B (en) 2012-12-21 2012-12-21 Method for detecting residual disinfecting Cetyltrimethylammonium Chloride used in production process of sodium hyaluronate

Publications (2)

Publication Number Publication Date
CN103048319A CN103048319A (en) 2013-04-17
CN103048319B true CN103048319B (en) 2015-02-18

Family

ID=48061037

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210563535.0A Active CN103048319B (en) 2012-12-21 2012-12-21 Method for detecting residual disinfecting Cetyltrimethylammonium Chloride used in production process of sodium hyaluronate

Country Status (1)

Country Link
CN (1) CN103048319B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103389300A (en) * 2013-08-13 2013-11-13 南京大学 Method for detecting quaternary ammonium salt cationic surfactant
CN103616379B (en) * 2013-12-04 2015-09-09 江苏天诺新材料科技股份有限公司 The quantitative determination method of 4-propyl bromide content in zeolite synthesis waste liquid
CN104237219B (en) * 2014-08-20 2016-08-24 浙江大学 A kind of water quality quaternary ammonium salt semi-quantitative detection method
CN106442841B (en) * 2016-12-16 2018-09-14 上海景峰制药有限公司 The method for separating and detecting of cationic surfactant in a kind of drug
CN112773734A (en) * 2020-12-28 2021-05-11 杭州欧菲健康科技有限公司 Hyaluronic acid skin-changing essence and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1292089A (en) * 1998-01-28 2001-04-18 克拉里安特国际有限公司 Determining method for concentration of nonionic surfactants is aqueous alkaline solutions
CN101852739A (en) * 2010-05-21 2010-10-06 东北师范大学 Method for determining polysorbate nonionic surfactant

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1292089A (en) * 1998-01-28 2001-04-18 克拉里安特国际有限公司 Determining method for concentration of nonionic surfactants is aqueous alkaline solutions
CN101852739A (en) * 2010-05-21 2010-10-06 东北师范大学 Method for determining polysorbate nonionic surfactant

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Fluorescence-detecting cationic surfactants using luminescent CdTe quantum dots as probes;Xue-Lian Diao et al.;《Analytical and Bioanalytical Chemistry》;20071231;第388卷(第5-6期);1191-1197 *
Tensammetric studies of the separation of surfactants Part 1.Investigation of sources of error in precipitation of non-ionic surfactants with modified Dragendorff reagent;Bogdan Wyrwas et al.;《Analytica Chimica Acta》;19931221;第278卷(第1期);197-203 *
双十八烷基二甲基氯化铵活性物含量的紫外-可见光度法测定;陈鑫琪 等;《工业水处理》;20120229;第32卷(第2期);77-79 *
溴甲酚紫-十六烷基二甲基苄基溴化铵法测定废水中阴离子表面活性剂含量;李来丙 等;《化工环保》;20051231;第25卷(第1期);68-71 *

Also Published As

Publication number Publication date
CN103048319A (en) 2013-04-17

Similar Documents

Publication Publication Date Title
CN103048319B (en) Method for detecting residual disinfecting Cetyltrimethylammonium Chloride used in production process of sodium hyaluronate
Loyo-Rosales et al. Migration of nonylphenol from plastic containers to water and a milk surrogate
Geng et al. A new fluorescent sensor for detecting p-nitrophenol based on β-cyclodextrin-capped ZnO quantum dots
Souza et al. Spectrophotometric determination of diclofenac in pharmaceutical preparations
CN102276624B (en) Olanzapine related substance and preparation method as well as high-efficiency liquid-phase chromatographic analysis method thereof
CN102564982A (en) Method for determining and correcting cyanide
Zhan et al. Selective spectrophotometric determination of paracetamol with sodium nitroprusside in pharmaceutical and biological samples
Panditrao et al. Stability-indicating HPLC determination of pramipexole dihydrochloride in bulk drug and pharmaceutical dosage form
CN105116037A (en) Manufacturing method for ribavirin molecular imprinting potentiometric sensor
CN101732243B (en) Stable methyl naltrexone injection and preparation method thereof
Gurupadayya et al. Spectrophotometric determination of meloxicam by sodium nitroprusside and 1, 10-phenanthroline reagents in bulk and its pharmaceutical formulation
CN105300945B (en) A kind of fluorescence quenching method of quantitative analysis chitosan
Picciolini et al. aquo-DESs: Water-based binary natural deep eutectic solvents
Maheshwari et al. Simple titrimetric method to estimate ketoprofen in bulk using mixed hydrotropy
JP5903017B2 (en) Quantitation method, quantification device and quantification kit
Saad et al. Flow-through chloroquine sensor and its applications in pharmaceutical analysis
JP5372696B2 (en) Determination of dimethylaminoethyl methacrylate-containing copolymer
CN103940876A (en) Ionic liquid/surface active agent modified glassy carbon electrode as well as preparation method and application thereof
EP3508840A1 (en) Standard reagent kit for dialysis fluid analysis, and aqueous solution for standard reagent, dialysis fluid, and artificial kidney fluid replenishment
CN106324137B (en) A kind of chromatogram quantitative analysis of the liquid phase method of 2- ethyl hydrazine and tetrahydro -2- ethyl hydrazine in hydrogen-peroxide working solution
CN108088929B (en) Analysis method of L-phenylglycine ethyl dane potassium salt
CN106811190A (en) A kind of fluorescence probe and its preparation and the application in ozone is detected
JP2021028304A (en) Method for producing ferric citrate aqueous solution
CN102914466B (en) A kind of method to cell pretreatment to be checked and agents useful for same thereof
Jiang et al. A New Nanocatalytic Spectrophotometric Assay for Cationic Surfactant Using Phosphomolybdic Acid‐Formic Acid‐Nanogold as Indicator Reaction

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: 200120 Shanghai city Baoshan District Luo Road No. 50

Patentee after: Shanghai Jingfeng Pharmaceutical Co., Ltd.

Address before: 200120 Shanghai city Baoshan District Luo Road No. 50

Patentee before: Shanghai Jingfeng Pharmaceutical Co., Ltd.